Cargando…
Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients
Germline variants such as BRCA1/2 play an important role in tumorigenesis and clinical outcomes of cancer patients. However, only a small fraction (i.e., 5–10%) of inherited variants has been associated with clinical outcomes (e.g., BRCA1/2, APC, TP53, PTEN and so on). The challenge remains in using...
Autores principales: | Milanese, Jean-Sébastien, Tibiche, Chabane, Zou, Jinfeng, Meng, Zhigang, Nantel, Andre, Drouin, Simon, Marcotte, Richard, Wang, Edwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825127/ https://www.ncbi.nlm.nih.gov/pubmed/31701019 http://dx.doi.org/10.1038/s41698-019-0100-7 |
Ejemplares similares
-
eTumorMetastasis: A Network-based Algorithm Predicts Clinical Outcomes Using Whole-exome Sequencing Data of Cancer Patients
por: Milanese, Jean-Sébastien, et al.
Publicado: (2021) -
Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome
por: McGee, Shauna R., et al.
Publicado: (2017) -
Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia
por: Lalonde, Marie-Eve, et al.
Publicado: (2022) -
The human phosphotyrosine signaling network: Evolution and hotspots of hijacking in cancer
por: Li, Lei, et al.
Publicado: (2012) -
Role of germline variants in the metastasis of breast carcinomas
por: Santonja, Ángela, et al.
Publicado: (2022)